SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Winska-Wiloch, H.
Right arrow Articles by Isenberg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winska-Wiloch, H.
Right arrow Articles by Isenberg, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Immunogenic properties of synthetic fragments of Sm-D protein in normal and lupus mice

H. Winska-Wiloch

Division of Rheumatology, Department of Medicine and Department of Immunology, University College London, UK

S. Muller

UPR 9021, Institut de Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France

DR Katz

Division of Rheumatology, Department of Medicine and Department of Immunology, University College London, UK

L. Wilkinson

Division of Rheumatology, Department of Medicine and Department of Immunology, University College London, UK

PR Hutchings

Division of Rheumatology, Department of Medicine and Department of Immunology, University College London, UK

DA Isenberg

Division of Rheumatology, Department of Medicine and Department of Immunology, University College London, UK

Antibodies against the Sm antigen are characteristic of systemic lupus erythematosus (SLE). They are found in 20-30% of SLE patients and it has been shown previously that up to 70% of SLE sera react with synthetic fragments 1-20 and 44-67 of the Sm-D polypeptide. To determine whether injections of these peptides might be pathogenic both were administered intraperitoneally into normal mouse strains BALB/c (H-2d), B10/brown (H-2k) and C57BL/6 (H-2b) and an autoimmune strain MRL/1pr (H-2k). IgG antibodies against peptide 1-20 were detected by ELISA in the sera of BALB/c and MRL/1pr mice but not in the sera of B10/brown and C57BL/6 mice. IgG antibodies against peptide 44-67 were found in the sera of BALB/c, B10/brown and MRL/1pr mice but not in the sera of C57BL/6 mice. Neither fragment induced a response against the whole Sm-D antigen as detected by Western blotting. Reactivity to synthetic fragments from other nuclear antigens was however detected in the sera of MRL/1pr mice, especially in those mice injected with Sm-D peptide 44-67 emulsified in Freund's adjuvant. Following immunization with Sm-D peptides, antibodies to ssDNA or dsDNA were not detected in the sera of BALB/c, B10/brown and C57BL/6 mice and in the MRL/1pr mice the naturally occurring production of these antibodies was not enhanced. No difference in IgG deposition in the renal glomeruli of the mice injected with the peptides compared with the control groups was observed. These results suggest that the humoral response to the Sm-D fragment is, at least partially, controlled by the MHC haplotype of the recipient mice, is related to dose and type of immunogen, and is also influenced by the presence of Freund's adjuvant. It is evident that although the sera of many SLE patients recognize either or both the 1-20 and 44-67 peptides, these peptides when injected into MRL/1pr mice are not directly pathogenic.

Key Words: animal models of lupus • anti-Sm antibodies • Sm-D synthetic peptides • intramolecular epitope spreading

Lupus, Vol. 6, No. 8, 656-667 (1997)
DOI: 10.1177/096120339700600807


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
U. S. Deshmukh, H. Bagavant, D. Sim, V. Pidiyar, and S. M. Fu
A SmD Peptide Induces Better Antibody Responses to Other Proteins within the Small Nuclear Ribonucleoprotein Complex than to SmD Protein via Intermolecular Epitope Spreading
J. Immunol., February 15, 2007; 178(4): 2565 - 2571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. T. McClain, P. A. Ramsland, K. M. Kaufman, and J. A. James
Anti-Sm Autoantibodies in Systemic Lupus Target Highly Basic Surface Structures of Complexed Spliceosomal Autoantigens
J. Immunol., February 15, 2002; 168(4): 2054 - 2062.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M Chang, S E Walker, and R W Hoffman
Immunization with a bacterial ATP-binding cassette transporter fragment suppresses autoimmunity and prolongs survival in MRL/lpr lupus-prone mice
Lupus, November 1, 2000; 9(9): 655 - 663.
[Abstract] [PDF]



Advertisement